ADC Therapeutics SA Common Shares (ADCT)
ADCT trades on NYSE in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.70
-8.60% on the day
Market cap
$217.0M
Micro cap
Revenue · 2025
$81.4M
+14.9% on 2024
Net income · 2025
-$142.6M
-175.3% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | ADCT on NYSE |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Switzerland |
| IPO year | 2020 |
| SEC CIK | 0001771910 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | V8 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $81.4M |
| Net income | -$142.6M |
| Operating income | -$121.5M |
| Net margin | -175.3% |
| Operating margin | -149.3% |
| Revenue growth | +14.9% |
| Cash | $261.3M |
| Total assets | $323.1M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.7× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2026-04-15 |
| Latest annual report | 10-K | 2026-03-10 |
| Latest quarterly / interim | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-10-13 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-04-20 |
Source: SEC EDGAR submissions feed, 435 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| MGNX | MacroGenics Inc. | $3.42 | -8.06% | $217.9M |
| CAMP | CAMP4 Therapeutics Corporation | $3.43 | -6.28% | $215.2M |
| EVMN | Evommune Inc. | $5.88 | -2.81% | $213.4M |
| AKBA | Akebia Therapeutics Inc. | $0.7700 | -2.56% | $213.4M |
| PYXS | Pyxis Oncology Inc. | $1.85 | -7.96% | $221.2M |
| SIGA | SIGA Technologies Inc. | $3.08 | -2.53% | $221.3M |
| KROS | Keros Therapeutics Inc. | $11.23 | -3.27% | $222.7M |
| SLGL | Sol-Gel Technologies Ltd. | $68.30 | -5.66% | $223.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier